Bridging Preclinical to Clinical Development - A Swiss Biotech Insight Event
Leveraging Proven Strategies for Holistic Biomarkers, Advanced Modalities and Technology Insights
📍 Agora Cancer Research Centre Lausanne
In this Insight series event, the Swiss Biotech Association joins forces with Labcorp to explore key learnings from biomarker-informed development, showcase cutting-edge analytical technologies for enhanced data collection and interpretation, and examine the integration of multi-omics approaches—all through the lens of real-world experience and case studies that support smarter decision-making.
Program
11:30 – 13:00 Registration and networking lunch
13:00 – 14:00 Welcome and opening session
Michael Altofer, CEO, Swiss Biotech Association
Julia Djonova, Head of the Advanced Therapy Medicinal Products (ATMP) department, Swissmedic
Stefano Romanelli, Senior Government Affairs Manager, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
14:00 – 15:15 Discovery to preclinical innovation: Setting the scientific foundation
Dan Snell, SVP Research & Preclinical Development, Numab
Giusy Di Conza, Head of Research, Ionctura
Stephanie Jungmichel, Head of Pharmacology, CDR Life
James Munday, Head Global Immunology & Immunotoxicology, Labcorp
15:45 – 17:15 Strategy & clinical execution: Linking science to business impact
